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ABSTRACT
Introduction: The management of sensitive
skin, which affects over 60% of the general
population, has been a long-standing challenge
for both patients and clinicians. Because
defective epidermal permeability barrier is one
of the clinical features of sensitive skin,
barrier-enhancing products could be an
optimal regimen for sensitive skin. In the
present study, we evaluated the efficacy and
safety of two barrier-enhancing products, i.e.,
Atopalm Multi-Lamellar Emulsion (MLE)
Cream and Physiogel Intensive Cream for
sensitive skin.
Methods: 60 patients with sensitive skin, aged
22–40 years old, were randomly assigned to one
group treated with Atopalm MLE Cream, and
another group treated with Physiogel Intensive
Cream twice daily for 4 weeks. Lactic acid
stinging test scores (LASTS), stratum hydration
(SC) and transepidermal water loss (TEWL) were
assessedbefore,2 and4 weeksafter the treatment.
Results: Atopalm MLE Cream significantly
lowered TEWL after 2 and 4 weeks of
treatment (p\0.01). In contrast, Physiogel
Intensive Cream significantly increased TEWL
after 2 weeks of treatment (p\0.05) while
TEWL significantly decreased after 4-week
treatments. Moreover, both Atopalm MLE
Cream and Physiogel Intensive Cream
significantly increased SC hydration, and
improved LASTS after 4 weeks of treatment.
Conclusion: Both barrier-enhancing products
are effective and safe for improving epidermal
functions, including permeability barrier, SC
hydration and LASTS, in sensitive skin. These
products could be a valuable alternative for
management of sensitive skin.
Funding: Veterans Affairs Medical Center, San
Francisco, California, USA, and NeoPharm Co.,
Ltd., Daejeon, Korea.
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INTRODUCTION
Sensitive skin is a skin condition that is
hypersensitive to various external stimuli. The
prevalence of sensitive skin in the general
population is over 60% in both males and
females [1]. In the general population, over
50% have suffered sensitive skin for over
5 years, and more than 42% have over a
10-year history of sensitive skin [2]. In over
30% of this population their sensitive skin
worsened [2]. The prevalence rate is higher in
African-American than in Caucasians,
particularly in the genital area [1, 3]. On the
face and genital area, females have a higher
prevalence than males [1]. Sensitive skin can be
caused by a variety of external and internal
factors, including sun exposure, psychological
stress, wind and hot or cold weather conditions
[1]. Among these factors, use of cosmetic
products is the most common cause [4]. For
example, use of inappropriate washing
emulsion can elevate both skin surface pH and
transepidermal water loss (TEWL) [5] which in
turn can induce or exacerbate cutaneous
inflammation [6–9]. Certain dermatoses, such
as atopic dermatitis, are associated with
sensitive skin [4].
The prevention and treatment of sensitive
skin have been a challenge for both patients and
clinicians due to its uncertain etiology and
pathogenesis. However, sensitive skin features
a number of abnormalities in its biophysical
properties, including increased TEWL and skin
erythema index, reduced stratum hydration
(SC), and compromised SC integrity. Cho et al.
did, however, show no difference in TEWL
between sensitive skin and normal skin
[10–13]. Moreover, a marked elevation in both
skin surface pH and TEWL are observed in
subjects with sensitive skin following topical
application of lactic acid [14, 15]. Among these
changes, increased TEWL, indicating a
disrupted permeability barrier, has significant
impact on cutaneous function. First, disruption
of permeability barrier induces cutaneous
inflammation via stimulation of
proinflammatory cytokine release [16–20],
inflammatory cell maturation and infiltration
[9, 21–23] while inflammation is a
pathophysiological feature of sensitive skin
[24]. Second, barrier disruption increases the
density of mast cell, a major source of
histamine, in the dermis [7] whereas release of
histamine can cause itching upon external
stimuli [25]. The increased histamine could
further disrupt epidermal permeability barrier
via inhibition of keratinocyte differentiation
and lipid production [26, 27]. Third,
compromised permeability barrier increases
cutaneous sensitivity to allergens through
facilitation of allergen penetration [28] while
increased transcutaneous penetration of
substances is another feature of sensitive skin
[29–31]. Taken together, compromised
epidermal permeability barrier plays a crucial
role in the pathogenesis of sensitive skin.
Therefore, the strategies to enhance epidermal
permeability barrier have been recommended
by experts for the management of sensitive skin
[32, 33]. However, the availability of
barrier-enhancing products for sensitive skin is
still limited. In the present study, we compared
the efficacy of Physiogel Intensive Cream
(Stiefel Laboratories, Inc. Middlesex, UK) and
Atopalm Multi-Lamellar Emulsion (MLE)
Cream (NeoPharm Co., Ltd, Daejeon, Korea)
for improving epidermal permeability barrier in
Chinese with sensitive skin.
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METHODS
Subjects
A randomized, double-blind controlled clinical
trial was conducted in 60 Chinese females with
sensitive skin in an outpatient clinic. The
inclusion criteria included Chinese female,
aged 20–40 years old, with sensitive skin, and
Lactic Acid Sting Test (LAST) score C3 at 2.5 and
5 min. The exclusion criteria included pregnant
women, nursing mothers, women planning to
be pregnant in the next 3 months, receiving or
going to receive any medications or any
cosmetology treatments within the last
3 months and during the study period, direct
facial exposure to sunlight or artificial UV
irradiation without protection over the last
2 h, known allergic or sensitive to any
ingredients in the test products and not using
any other products during the study period
(excluding lipstick, eyeliner or eye shadow). All
subjects were non-atopic and with no skin
disorders which are known to influence
epidermal function. Informed consent was
obtained from all individual participants in
the study. Subjects were alternately assigned to
group A or B after completion of consent form.
All procedures performed in studies involving
human participants were in accordance with
the ethical standards of the institutional and/or
national research committee and with the 1964
Helsinki declaration and its later amendments
or comparable ethical standards. The protocol
of this study was approved by human research
committee of Peking University First Hospital,
Beijing, China.
LAST
LAST was performed by applying 50 ll of 5%
lactic acid solution with two layers of filter
paper (diameter 0.5 cm) to the nasolabial folds.
Skin stinging was evaluated by a 4-point scale
(0, absence of stinging; 1, weak stinging; 2,
moderate stinging; 3, strong stinging) 0, 2.5, 5
and 8 min after the application.
Materials and Treatments
30 subjects in group A were treated with
Atopalm MLE Cream while 30 subjects in
group B were treated with Physiogel Intensive
Cream twice daily for 4 weeks. The major active
ingredients in these two products are detailed in
Table 1. Products were only applied to the face.
This study was carried out at the Department of
Dermatology and Venereology, Peking
University First Hospital, Beijing, China,
between April and August 2015.
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Squalane Simmondsia chinensis (Jojoba)
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Pentylene glycol Olea europaea (Olive) fruit oil









a Information was provided by NeoPharm Co., Ltd.,
Daejeon, Korea
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Assessment of Efficacy
TEWL, an indicator of epidermal permeability
barrier function, was measured using a
TewaMeter TM210 (Courage ? Khazaka
electronic GmbH, Cologne, Germany) while
SC capacitance, an indicator of SC hydration,
was measured on the right zygomatic area using
a Corneometer CM 825 (Courage ? Khazaka
electronic GmbH, Cologne, Germany) before,
14 and 28 days after treatments. Meanwhile, the
LAST was also performed on the nasolabial
folds. All tests were carried out under
controlled environmental conditions at the
humidity of 40 ± 10% and temperature of
22 ± 2 C. Subjects rested peacefully in such
environment for at least 30 min before the tests.
Assessment of Adverse Event
Adverse events were assessed 2 and 4 weeks after
treatments, using following numerical grading
system: 0, no adverse event; 1, occasionally
mild; 2, moderate, but endurable; 3, severe,
with predominant symptoms. Subjects with
adverse reaction Cgrade 2 were asked to
discontinue the trial.
Statistical Analyses
Data are expressed as mean ± SEM except
otherwise indicated in the text. Data were
analyzed using GraphPad Prism 4 (GraphPad
Software, Inc., La Jolla, CA,USA). Nonparametric
two-tailed T test was used to determine
significant differences between two groups.
RESULTS
Out of 60 subjects, one subject experienced
facial redness after application of Atopalm MLE
Cream. The subject refused to have a patch test.
The lesion disappeared 1 day after
discontinuation of using the cream. The
remaining 59 subjects completed the trial with
no sign of adverse reaction. The demographic
data of these subjects were detailed in Table 2.
Both Products Improve Epidermal
Permeability Barrier
Since Atopalm MLE Cream and Physiogel
Intensive Cream contain stratum corneum lipids,
which benefit the epidermal permeability barrier
[35–37], we first assessed epidermal permeability
barrier function after topical applications of these
products. As shown in Fig. 1a, topical applications
of Atopalm MLE Cream for 2 weeks induced an
over 20% reduction in TEWL. In contrast,
Physiogel Intensive Cream caused an 11%
increase in TEWL after 2 weeks of treatment.
After 4 weeks of treatments, both Atopalm MLE
Cream and Physiogel Intensive Cream benefited
the epidermal permeability barrier while the
reduction in TEWL was more dramatic in
Atopalm MLE Cream-treated than in Physiogel
Intensive Cream-treated subjects.
Our prior studies have demonstrated that
topical stratum corneum lipids or their
containing product improve stratum corneum
hydration [38–40], which is reduced in sensitive
skin [10]. We next determined whether topical
treatments with these products also improve
stratum corneum hydration in sensitive skin.
Indeed, both products significantly increased
stratum corneum hydration after 4 weeks of
treatment although the improvement of
Table 2 Demographic data of subjects
Group Number Age range (years) Mean SD
Group A 29 24–40 28 4.38
Group B 30 22–40 30.8 6.79
SD standard deviation
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stratum corneum hydration was not dramatic
after 2 weeks of treatment (Fig. 1b). The
improvement in stratum corneum hydration
was no different between these two products
after 2 or 4 weeks of treatment. Taken together,
these results demonstrated that topical
applications of either product improves
epidermal permeability barrier and stratum
corneum hydration in subjects with sensitive
skin.
Both Products Improve LASTS
Sensitive skin is characterized by an enhanced
response to LAST [30, 31], which is likely due to
poor permeability barrier that facilitates the
penetration of lactic acid into skin [28, 29].
Since both Atopalm MLE Cream and Physiogel
Intensive Cream improved epidermal
permeability barrier, we next assessed whether
these two products also improve LAST scores. As
seen in Fig. 2, after 2 weeks of treatments with
these products, LAST scores were reduced by
14%. Further reductions in LAST scores were
observed after 4 weeks of treatment
(27.3 ± 7.2% for Atopalm MLE Cream and
34.1 ± 8% for Physiogel Intensive Cream, no
significant difference was observed between
these two products). These results demonstrate
that Atopalm MLE Cream- and Physiogel
Intensive Cream-induced improvement of
permeability barrier is paralleled by a
reduction in LAST scores.
Fig. 1 The effects of barrier-enhancing products on the
epidermal permeability barrier in subjects with sensitive
skin. Subjects’ faces with sensitive skin were treated with
either Atopalm MLE Cream or Physiogel Intensive
Cream twice daily for 4 weeks. TEWL and stratum
corneum hydration were measured before, 2 and 4 weeks
after treatments as described in ‘‘Methods’’. a Depicts the
inﬂuences of topical products on TEWL after 2 and
4 weeks of treatments. b Displays the effects of topical
products on stratum corneum hydration after 2 and
4 weeks of treatments. For both TEWL and stratum
corneum hydration, the data were expressed as % changes
from baseline. Signiﬁcances and number of subjects are
indicated in the ﬁgures. MLE multi-lamellar emulsion, SC
stratum hydration, TEWL transepidermal water loss
Fig. 2 The effects of barrier-enhancing products on
LASTS in subjects with sensitive skin. Subjects’ faces with
sensitive skin were treated with either Atopalm MLE
Cream or Physiogel Intensive Cream twice daily for
4 weeks. LASTS was performed before, 2 and 4 weeks after
treatments as described in ‘‘Methods’’. Skin stinging was
evaluated by a 4-point scale. The data were expressed as %
improvement from baseline. Signiﬁcances and number of
subjects are indicated in the ﬁgures. LASTS lactic acid
sting test scores, MLE Multi-Lamellar Emulsion
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DISCUSSION
Sensitive skin is a common skin disorder. The
preventive and therapeutic regimens are limited
although moisturizers are available [41–43]. In
the present study, we showed that topical
applications of these two products improved
LAST scores, likely resulting from enhanced
epidermal permeability barrier function in
subjects with sensitive skin. Although both
products contain stratum corneum lipids,
which are known to improve epidermal
permeability barrier in both normal and
diseased skin [36, 37, 44], topical Atopalm
MLE Cream induced a rapid improvement in
epidermal permeability barrier after 2 weeks of
treatment. In contrast, Physiogel Intensive
Cream increased TEWL after 2 weeks of
treatment. The mechanisms underlying the
difference in the efficacy between the two
products are unclear. However, several
potential variations in the formulations could
affect the efficacy. First, the effects of stratum
corneum lipid mixture on epidermal
permeability barrier are largely determined by
the molar ratio of these lipids [36]. The molar
ratio of these lipids could be different between
these two products. Second, the composition of
the lipid mixture can also affect the efficacy of
the products. For example, linoleic acid is not
only the structural requirement for barrier
formation, but also activates peroxisome
proliferator-activated receptor c (PPAR c) [45].
Activation of PPARc stimulates epidermal lipid
production and differentiation, both of which
benefit epidermal permeability barrier [46]. The
content of linoleic acid in cocos nucifera oil and
butyrospermum parkii, sources of linoleic acid
in Physiogel Intensive Cream, ranges 3–11%
[47, 48] while olea europaea (Olive) fruit oil and
vitis vinifera seed oil, ingredients in Atopalm
MLE Cream, are enriched in linoleic acid (as
high as over 70%) [49]. Third, both antioxidant
(tocopheryl acetate) and hyaluronate,
ingredients in Atopalm MLE Cream, benefit
the epidermal permeability barrier [50–52].
Moreover, myristoyl/palmitoyl oxostearamide/
arachamide MEA upregulates epidermal PPARa
expression [53]. The latter is crucial for
maintenance of epidermal permeability barrier
function [54]. Moreover, activation of either
PPARa or PPARc inhibits cutaneous
inflammation, which is a feature of sensitive
skin [46, 55]. Thus, the different efficacy of
these two products could be attributed to their
compositional differences.
Although there were no untreated controls
in the present study, the reduced TEWL value
unlikely reflected spontaneous remission of
disease due to the changes in humidity and/or
environmental temperature. The study was
carried from April (low humidity, spring) to
August (high humidity, summer) during which
environmental humidity and temperature
gradually increased. Previous studies have
shown that TEWL levels are lower in low
humidity than in high humidity in both mice
and humans [56, 57]. TEWL levels in humans
are higher in summer than in winter [58].
However, our results show that TEWL levels
were reduced after treatment. Thus, the
reduction in TEWL is likely attributable to the
products.
Previous studies have shown that disruption
of the epidermal permeability barrier enhances
percutaneous penetration of a substance [59,
60], and that enhancement of the epidermal
permeability barrier can decrease cutaneous
response to irritants [61] and improve
inflammation [44]. In addition to facilitating
percutaneous penetration of substances, a
compromised permeability barrier alone can
also provoke inflammation in sensitive skin.
Thus, improved barrier function induced by
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these two products may not only alleviate
inflammation, but may also prevent
substances from penetrating the skin,
suggesting potential utilization of these
products for the prevention and treatment of
sensitive skin. The present study also showed
that both products increased stratum corneum
hydration, which is low in sensitive skin.
Previous studies have demonstrated that
moisturizers improve sensitive skin. Hence, the
beneficial effect of these two products on
stratum corneum hydration provides another
rationale for their usage in treating sensitive
skin. However, whether other products, such as
diaper cream, cis-Urocanic Acid emulsion cream
and Canoderm that improves epidermal
permeability barrier in humans [62–64], also
benefits sensitive skin, remains to be
determined. Moreover, further clinical studies
are required to validate the efficacy and safety of
these products before they are widely
recommended to patients with sensitive skin.
CONCLUSION
Barrier-enhancing products such as AtopalmMLE
Cream and Physiogel Intensive Cream are
effective for improving the epidermal
permeability barrier, stratum corneum hydration
andLASTscores.Thebenefitsofbarrier-enhancing
products means that barrier-enhancing strategies
could be a valuable approach for preventing and
treating sensitive skin.
ACKNOWLEDGMENTS
Sponsorship for this study was funded in part by
the resources and facilities at the Veterans
Affairs Medical Center, San Francisco,
California, USA, and NeoPharm Co., Ltd.,
Daejeon, Korea, which sponsored graduate
students from Peking University to perform
the study. Article processing charges were
funded by NeoPharm Co., Ltd., Daejeon,
Korea. All authors had full access to all of the
data in this study and take complete
responsibility for the integrity of the data and
accuracy of the data analysis. All named authors
meet the International Committee of Medical
Journal Editors (ICMJE) criteria for authorship
for this manuscript, take responsibility for the
integrity of the work as a whole, and have given
final approval to the version to be published.
Disclosures. Man G and Man MQ have
nothing to disclose. Jeong S, Lee SH and Park
BD were employees of NeoPharm Co., Ltd.,
Daejeon, Korea. Wu Y received funding from
NeoPharm Co for supporting graduate students
to perform the study.
Compliance with ethics guidelines. All
procedures performed in studies involving
human participants were in accordance with
the ethical standards of the institutional and/or
national research committee and with the 1964
Helsinki declaration and its later amendments
or comparable ethical standards. The protocol
of this study was approved by human research
committee of Peking University First Hospital,
Beijing, China. Informed consent was obtained
from all individual participants in the study.
Open Access. This article is distributed under
the terms of the Creative Commons
Attribution-NonCommercial 4.0 International
License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits any noncommercial
use, distribution, and reproduction in any
medium, provided you give appropriate credit to
the original author(s) and the source, provide a
link to the Creative Commons license, and
indicate if changes were made.
Dermatol Ther (Heidelb) (2016) 6:47–56 53
REFERENCES
1. Farage MA. Does sensitive skin differ between men
and women? Cutan Ocul Toxicol. 2010;29:153–63.
2. Farage MA. Perceptions of sensitive skin: changes in
perceived severity and associations with
environmental causes. Contact Dermatitis.
2008;59:226–32.
3. FarageMA.Howdoperceptionsof sensitive skindiffer
at different anatomical sites? An epidemiological
study. Clin Exp Dermatol. 2009;34:e521–30.
4. Willis CM, Shaw S, De Lacharrie`re O, et al. Sensitive
skin: an epidemiological study. Br J Dermatol.
2001;145:258–63.
5. Bornkessel A, Flach M, Arens-Corell M, Elsner P,
Fluhr JW. Functional assessment of a washing
emulsion for sensitive skin: mild impairment of
stratum corneum hydration, pH, barrier function,
lipid content, integrity and cohesion in a controlled
washing test. Skin Res Technol. 2005;11:53–60.
6. Dudeck A, Suender CA, Kostka SL, von Stebut E,
Maurer M. Mast cells promote Th1 and Th17
responses by modulating dendritic cell maturation
and function. Eur J Immunol. 2011;41:1883–93.
7. Lin TK, Man MQ, Santiago JL, et al. Topical
antihistamines display potent anti-inflammatory
activity linked in part to enhanced permeability
barrier function. J Invest Dermatol.
2013;133:469–78.
8. Merad M, Ginhoux F, Collin M. Origin,
homeostasis and function of Langerhans cells and
other langerin-expressing dendritic cells. Nat Rev
Immunol. 2008;8:935–47.
9. Proksch E, Brasch J, Sterry W. Integrity of the
permeability barrier regulates epidermal Langerhans
cell density. Br J Dermatol. 1996;134:630–8.
10. Seidenari S, Francomano M, Mantovani L. Baseline
biophysical parameters in subjects with sensitive
skin. Contact Dermatitis. 1998;38:311–5.
11. Pinto P, Rosado C, Parreira˜o C, Rodrigues LM. Is
there any barrier impairment in sensitive skin?: a
quantitative analysis of sensitive skin by
mathematical modeling of transepidermal water
loss desorption curves. Skin Res Technol.
2011;17:181–5.
12. Muizzuddin N, Marenus KD, Maes DH. Factors
defining sensitive skin and its treatment. Am J
Contact Dermat. 1998;9:170–5.
13. Cho HJ, Chung BY, Lee HB, Kim HO, Park CW, Lee
CH. Quantitative study of stratum corneum
ceramides contents in patients with sensitive skin.
J Dermatol. 2012;39:295–300.
14. Issachar N, Gall Y, Borell MT, Poelman MC. pH
measurements during lactic acid stinging test in
normal and sensitive skin. Contact Dermatitis.
1997;36:152–5.
15. Herna´ndez-Blanco D, Castanedo-Ca´zares JP,
Ehnis-Pe´rez A, Jasso-A´vila I, Conde-Salazar L,
Torres-A´lvarez B. Prevalence of sensitive skin and
its biophysical response in a Mexican population.
World J Dermatol. 2013;2:1–7.
16. Tsai JC, Feingold KR, Crumrine D, Wood LC,
Grunfeld C, Elias PM. Permeability barrier
disruption alters the localization and expression of
TNF alpha/protein in the epidermis. Arch Dermatol
Res. 1994;286:242–8.
17. Wood LC, Jackson SM, Elias PM, Grunfeld C,
Feingold KR. Cutaneous barrier perturbation
stimulates cytokine production in the epidermis
of mice. J Clin Invest. 1992;90:482–7.
18. Wood LC, Stalder AK, Liou A, et al. Barrier
disruption increases gene expression of cytokines
and the 55 kD TNF receptor in murine skin. Exp
Dermatol. 1997;6:98–104.
19. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld
C, Feingold KR. Occlusion lowers cytokine mRNA
levels in essential fatty acid-deficient and normal
mouse epidermis, but not after acute barrier
disruption. J Invest Dermatol. 1994;103:834–8.
20. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld
C, Feingold KR. Barrier disruption stimulates
interleukin-1 alpha expression and release from a
pre-formed pool in murine epidermis. J Invest
Dermatol. 1996;106:397–403.
21. Proksch E, Brasch J. Influence of epidermal
permeability barrier disruption and Langerhans’
cell density on allergic contact dermatitis. Acta
Derm Venereol. 1997;77:102–4.
22. Katoh N, Hirano S, Kishimoto S, Yasuno H. Acute
cutaneous barrier perturbation induces maturation
of Langerhans’ cells in hairless mice. Acta Derm
Venereol. 1997;77:365–9.
23. Nishijima T, Tokura Y, Imokawa G, Seo N,
Furukawa F, Takigawa M. Altered permeability and
disordered cutaneous immunoregulatory function
in mice with acute barrier disruption. J Invest
Dermatol. 1997;109:175–82.
54 Dermatol Ther (Heidelb) (2016) 6:47–56
24. Pons-Guiraud A. Sensitive skin: a complex and
multifactorial syndrome. J Cosmet Dermatol.
2004;3:145–8.
25. Inami Y, Andoh T, Sasaki A, Kuraishi Y.
Surfactant-induced itching and the involvement
of histamine released from keratinocytes. Yakugaku
Zasshi. 2012;132:1225–30.
26. Gschwandtner M, Mildner M, Mlitz V, et al.
Histamine suppresses epidermal keratinocyte
differentiation and impairs skin barrier function
in a human skin model. Allergy. 2013;68:37–47.
27. Gutowska-Owsiak D, Salimi M, Selvakumar TA,
Wang X, Taylor S, Ogg GS. Histamine exerts
multiple effects on expression of genes associated
with epidermal barrier function. J Investig Allergol
Clin Immunol. 2014;24:231–9.
28. Scharschmidt TC, Man MQ, Hatano Y, et al.
Filaggrin deficiency confers a paracellular barrier
abnormality that reduces inflammatory thresholds
to irritants and haptens. J Allergy Clin Immunol.
2009;124:496–506.
29. Roussaki-Schulze AV, Zafiriou E, Nikoulis D, Klimi
E, Rallis E, Zintzaras E. Objective biophysical
findings in patients with sensitive skin. Drugs Exp
Clin Res. 2005;31S:17–24.
30. Issachar N, Gall Y, Borrel MT, Poelman MC.
Correlation between percutaneous penetration of
methyl nicotinate and sensitive skin, using laser
Doppler imaging. Contact Dermatitis.
1998;39:182–6.
31. Berardesca E, Cespa M, Farinelli N, Rabbiosi G,
Maibach H. In vivo transcutaneous penetration of
nicotinates and sensitive skin. Contact Dermatitis.
1991;25:35–8.
32. https://rationale.com/expert-advice/protocol-sen
sitive-skin. Accessed Sept 30, 2015.
33. Berardesca E, Farage M, Maibach H. Sensitive skin:
an overview. Int J Cosmet Sci. 2013;35:2–8.
34. http://www.cosdna.com/eng/cosmetic_bb281217
29.html. Accessed Jan 12, 2016.
35. http://www.physiogel.com/sg[Date. Accessed Sept
30, 2015.
36. Man MQ, Feingold KR, Thornfeldt CR, Elias PM.
Optimization of physiological lipid mixtures for
barrier repair. J Invest Dermatol.
1996;106:1096–101.
37. Yang L, Mao-Qiang M, Taljebini M, Elias PM,
Feingold KR. Topical stratum corneum lipids
accelerate barrier repair after tape stripping,
solvent treatment and some but not all types of
detergent treatment. Br J Dermatol.
1995;133:679–85.
38. Man MQ, Elias P, Feingold KR, Thornfeldt CR, Elias
PM. A natural lipid mixture improves barrier
function and skin hydration in both human and
murine skin. J Soc Cosmet Chem. 1997;47:157–66.
39. Wang F, Man MQ, Elias P. A natural lipid mixture
improves skin hydration in ichthyosis vulgaris. Int J
Dermatol. 1997;36:876–7.
40. Rim JH, Jo SJ, Park JY, Park BD, Youn JI. Electrical
measurement of moisturizing effect on skin
hydration and barrier function in psoriasis
patients. Clin Exp Dermatol. 2005;30:409–13.
41. Kikuchi K, Kobayashi H, Hirao T, Ito A, Takahashi
H, Tagami H. Improvement of mild inflammatory
changes of the facial skin induced by winter
environment with daily applications of a
moisturizing cream. A half-side test of biophysical
skin parameters, cytokine expression pattern and
the formation of cornified envelope. Dermatology.
2003;207:269–75.
42. Vie K, Pons-Guiraud A, Dupuy P, Maibach H.
Tolerance profile of a sterile moisturizer and
moisturizing cleanser in irritated and sensitive
skin. Am J Contact Dermat. 2000;11:161–4.
43. Weber TM, Ceilley RI, Buerger A, et al. Skin
tolerance, efficacy, and quality of life of patients
with red facial skin using a skin care regimen
containing Licochalcone A. J Cosmet Dermatol.
2006;5:227–32.
44. Chamlin SL, Kao J, Frieden IJ, et al.
Ceramide-dominant barrier repair lipids alleviate
childhood atopic dermatitis: changes in barrier
function provide a sensitive indicator of disease
activity. J Am Acad Dermatol. 2002;47:198–208.
45. Sasaki T, Fujii K, YoshidaK, et al. Peritonealmetastasis
inhibition by linoleic acid with activation of
PPARgamma in human gastrointestinal cancer cells.
Virchows Arch. 2006;448:422–7.
46. Mao-Qiang M, Fowler AJ, Schmuth M, et al.
Peroxisome-proliferator-activated receptor
[PPAR]-gamma activation stimulates keratinocyte
differentiation. J Invest Dermatol. 2004;123:305–12.
47. Laureles LR, Rodriguez FM, Rean˜o CE, Santos GA,
Laurena AC, Mendoza EM. Variability in fatty acid
and triacylglycerol composition of the oil of
coconut (Cocos nucifera L.) hybrids and their
parentals. J Agric Food Chem. 2002;50:1581–6.
48. Israel MO. Effects of topical and dietary use of shea
butter on animals. Am J Life Sci. 2014;2:303–7.
Dermatol Ther (Heidelb) (2016) 6:47–56 55
49. Rubio M, Alvarez-Ortı´ M, Alvarruiz A, Ferna´ndez E,
Pardo JE. Characterization of oil obtained from
grape seeds collected during berry development.
J Agric Food Chem. 2009;57:2812–5.
50. Jerajani HR, Mizoguchi H, Li J, Whittenbarger DJ,
Marmor MJ. The effects of a daily facial lotion
containing vitamins B3 and E and provitamin B5
on the facial skin of Indian women: a randomized,
double-blind trial. Indian J Dermatol Venereol
Leprol. 2010;76:20–6.
51. Bourguignon LY, Wong G, Xia W, Man MQ,
Holleran WM, Elias PM. Selective matrix
(hyaluronan) interaction with CD44 and
RhoGTPase signaling promotes keratinocyte
functions and overcomes age-related epidermal
dysfunction. J Dermatol Sci. 2013;72:32–44.
52. Bourguignon LY, Ramez M, Gilad E, et al.
Hyaluronan-CD44 interaction stimulates
keratinocyte differentiation, lamellar body
formation/secretion, and permeability barrier
homeostasis. J Invest Dermatol. 2006;126:1356–65.
53. Lee SE, Jung MK, Oh SJ, Jeong SK, Lee SH.
Pseudoceramide stimulates peroxisome
proliferator-activated receptor-a expression in a
murine model of atopic dermatitis: molecular
basis underlying the anti-inflammatory effect and
the preventive effect against steroid-induced barrier
impairment. Arch Dermatol Res. 2015;307:781–92.
54. Man MQ, Choi EH, Schmuth M, et al. Basis for
improved permeability barrier homeostasis induced
by PPAR and LXR activators: liposensors stimulate
lipid synthesis, lamellar body secretion, and
post-secretory lipid processing. J Invest Dermatol.
2006;126:386–92.
55. Sheu MY, Fowler AJ, Kao J, et al. Topical peroxisome
proliferator activated receptor-alpha activators
reduce inflammation in irritant and allergic
contact dermatitis models. J Invest Dermatol.
2002;118:94–101.
56. Denda M, Sato J, Masuda Y, et al. Exposure to a dry
environment enhances epidermal permeability
barrier function. J InvestDermatol. 1998;111:858–63.
57. Chou TC, Lin KH, Wang SM, et al. Transepidermal
water loss and skin capacitance alterations among
workers in an ultra-low humidity environment.
Arch Dermatol Res. 2005;296:489–95.
58. Song EJ, Lee JA, Park JJ, et al. A study on seasonal
variation of skin parameters in Korean males. Int J
Cosmet Sci. 2015;37:92–7.
59. Tsai JC, Guy RH, Thornfeldt CR, Gao WN, Feingold
KR, Elias PM. Metabolic approaches to enhance
transdermal drug delivery. 1. Effect of lipid
synthesis inhibitors. J Pharm Sci. 1996;85:643–8.
60. Elias PM, Tsai J, Menon GK, Holleran WM, Feingold
KR. The potential of metabolic interventions to
enhance transdermal drug delivery. J Investig
Dermatol Symp Proc. 2002;7:79–85.
61. Fartasch M, Schnetz E, Diepgen TL.
Characterization of detergent-induced barrier
alterations—effect of barrier cream on irritation.
J Investig Dermatol Symp Proc. 1998;3:121–7.
62. Garcia Bartels N, Lu¨nnemann L, Stroux A, Kottner J,
Serrano J, Blume-Peytavi U. Effect of diaper cream
and wet wipes on skin barrier properties in infants:
a prospective randomized controlled trial. Pediatr
Dermatol. 2014;31:683–91.
63. Peltonen JM, Pylkka¨nen L, Janse´n CT, et al. Three
randomised phase I/IIa trials of 5% cis-urocanic
acid emulsion cream in healthy adult subjects and
in patients with atopic dermatitis. Acta Derm
Venereol. 2014;94:415–20.
64. Buraczewska I, Berne B, Lindberg M, To¨rma¨ H,
Lode´n M. Changes in skin barrier function
following long-term treatment with moisturizers,
a randomized controlled trial. Br J Dermatol.
2007;156:492–8.
56 Dermatol Ther (Heidelb) (2016) 6:47–56
